Literature DB >> 26498903

Infectious Diseases Pharmacotherapy for Children With Cystic Fibrosis.

Leah Molloy, Kristen Nichols.   

Abstract

Cystic fibrosis (CF) affects several organs, most notably the lungs, which become predisposed to infections with potentially severe consequences. Because of physiologic changes and infection characteristics, unique approaches to antimicrobial agent selection, dosing, and administration are needed. To provide optimal acute and long-term care, pediatric health care providers must be aware of these patient features and common approaches to antimicrobial therapy in CF, which can differ significantly from those of other infectious diseases. The purpose of this article is to review common respiratory pathogens, pharmacology of commonly used antimicrobial agents, and unique pharmacokinetics and dosing strategies often used when treating children with CF.
Copyright © 2015 National Association of Pediatric Nurse Practitioners. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CF; Cystic Fibrosis ID Pharmacology; Cystic Fibrosis ID Pharmacotherapy

Mesh:

Substances:

Year:  2015        PMID: 26498903     DOI: 10.1016/j.pedhc.2015.07.010

Source DB:  PubMed          Journal:  J Pediatr Health Care        ISSN: 0891-5245            Impact factor:   1.812


  3 in total

Review 1.  Dental treatment for people with cystic fibrosis.

Authors:  N Harrington; P J Barry; S M Barry
Journal:  Eur Arch Paediatr Dent       Date:  2016-05-04

2.  Role of inhaled antibiotics in children and adolescents with cystic fibrosis: Experience from the tertiary care center.

Authors:  Danish Abdul Aziz; Aiza Abbas; Anusha Alam; Namrah Aziz
Journal:  Lung India       Date:  2022 May-Jun

3.  Comparison of respiratory pathogen colonization and antimicrobial susceptibility in people with cystic fibrosis bronchiectasis versus non-cystic fibrosis bronchiectasis: a protocol for a systematic review.

Authors:  Salony Verma; Joseph L Mathew; Pallab Ray
Journal:  Syst Rev       Date:  2021-01-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.